These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8247325)
21. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Britton P; Lu XC; Laskosky MS; Tortella FC Life Sci; 1997; 60(20):1729-40. PubMed ID: 9150412 [TBL] [Abstract][Full Text] [Related]
22. Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer 344 rats. Sakakibara Y; Mitha AP; Ayoub IA; Ogilvy CS; Maynard KI Brain Res; 2002 Mar; 931(1):68-73. PubMed ID: 11897090 [TBL] [Abstract][Full Text] [Related]
24. Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia. Liu R; Wang X; Liu Q; Yang SH; Simpkins JW Neurosci Lett; 2007 Mar; 415(3):237-41. PubMed ID: 17331646 [TBL] [Abstract][Full Text] [Related]
25. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Chan PH; Kamii H; Yang G; Gafni J; Epstein CJ; Carlson E; Reola L Neuroreport; 1993 Dec; 5(3):293-6. PubMed ID: 8298091 [TBL] [Abstract][Full Text] [Related]
26. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Dawson DA; Graham DI; McCulloch J; Macrae IM Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669 [TBL] [Abstract][Full Text] [Related]
28. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats. Ayoub IA; Lee EJ; Ogilvy CS; Beal MF; Maynard KI Neurosci Lett; 1999 Jan; 259(1):21-4. PubMed ID: 10027546 [TBL] [Abstract][Full Text] [Related]
29. Alteration of ischemic reperfusion injury in the rat neocortex by a potent antioxidant mexiletine. Chang CZ; Winardi D; Loh JK; Kung SS; Howng SL; Jeng AY; Kwan AL Acta Neurochir (Wien); 2002 Feb; 144(2):189-93; discussion 193. PubMed ID: 11862520 [TBL] [Abstract][Full Text] [Related]
30. Neuroprotective activity of tamoxifen in permanent focal ischemia. Kimelberg HK; Jin Y; Charniga C; Feustel PJ J Neurosurg; 2003 Jul; 99(1):138-42. PubMed ID: 12854756 [TBL] [Abstract][Full Text] [Related]
31. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Liou KT; Shen YC; Chen CF; Tsao CM; Tsai SK Brain Res; 2003 Dec; 992(2):159-66. PubMed ID: 14625055 [TBL] [Abstract][Full Text] [Related]
32. Activation of Akt by SC79 decreased cerebral infarct in early cerebral ischemia-reperfusion despite increased BBB disruption. Liu X; Kiss GK; Mellender SJ; Weiss HR; Chi OZ Neurosci Lett; 2018 Aug; 681():78-82. PubMed ID: 29859325 [TBL] [Abstract][Full Text] [Related]
33. Intravenous basic fibroblast growth factor produces a persistent reduction in infarct volume following permanent focal ischemia in rats. Sugimori H; Speller H; Finklestein SP Neurosci Lett; 2001 Mar; 300(1):13-6. PubMed ID: 11172928 [TBL] [Abstract][Full Text] [Related]
34. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. Steinberg GK; Kunis D; Saleh J; DeLaPaz R J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379 [TBL] [Abstract][Full Text] [Related]
36. Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats. Zhang YG; Liu TP Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):44-8. PubMed ID: 8737452 [TBL] [Abstract][Full Text] [Related]
37. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. Duverger D; MacKenzie ET J Cereb Blood Flow Metab; 1988 Aug; 8(4):449-61. PubMed ID: 2968987 [TBL] [Abstract][Full Text] [Related]
38. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. Brint S; Jacewicz M; Kiessling M; Tanabe J; Pulsinelli W J Cereb Blood Flow Metab; 1988 Aug; 8(4):474-85. PubMed ID: 3392112 [TBL] [Abstract][Full Text] [Related]
39. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Albers GW; Atkinson RP; Kelley RE; Rosenbaum DM Stroke; 1995 Feb; 26(2):254-8. PubMed ID: 7831698 [TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]